This change will take effect June 29, 2015
Overview and Clinical Utility:
Effective June 29, 2015 PathGroup Labs will begin offering the non-invasive Echosens FibroMeter diagnostic test for liver fibrosis and inflammation. This addition provides clients with superior testing results and improved turnaround time. In addition to current chemistry assays, FibroMeter utilizes two supplementary tests, platelet count and prothrombin index, to result a fibrosis, cirrhosis, and activity score.
Click Here to read more.